Keros Therapeutics Reports Recent First Quarter 2026 Financial Results

Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on ...

Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA

Pluvicto® PSMAddition oral presentation to highlight efficacy outcomes by disease volume and de novo/recurrent metastatic ...

BBC Race Across the World's Margo declares love for 'Liverpool brothers' Jo and Kush

Race Across the World's Margo has sent a heartfelt message to fellow Scouse contestants Jo and Kush. They have been taking ...

BBC Race Across the World's Margo shares heartbreaking message to late sister Julia

BBC Race Across the World contestant Margo Oakley has shared a special message to her late sister Julia. The 60-year-old has ...
The Barre-Montpelier Times Argus

Aspera Biomedicines Successfully Launches Second ADAR1p150 Crystallization Experiment to the International Space Station Aboard SpaceX CRS-34

Aspera Biomedicines Inc., a biotechnology company developing first-in-class therapies targeting cancer stem cells, today ...

Incyte CEO Says Post-Jakafi Growth Path Is Clearer as Pipeline Catalysts Build

President and CEO Bill Meury said the company’s post-Jakafi growth profile has become “much clearer” over the past year, pointing to continued growth in its commercial business, late-stage pipeline ...
Pharmaceutical Technology

Kyowa Kirin secures FDA approval for Crysvita dosing update

Kyowa Kirin has received approval from the FDA for a dosing update to the Crysvita prescribing information, introducing a new option for adults with XLH.

Keros Q1 Loss Wider Than Expected, Revenues Plunge Year Over Year

KROS posts a wider Q1 loss as revenues fall due to the absence of license revenues. The company advances rinvatercept and ...